Sorry, you need to enable JavaScript to visit this website.

Competitive Grants Program

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Implementing Shared Decision Making in Hemophilia Patient Care
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Rare Disease USA
    Improving the Vaccination Environment to Prevent Respiratory Infectious Diseases in Older Adults and High-Risk Individuals
    Release Date:
    Review Process: Pfizer Internal
    Translation: Japanese (link)
    Quality Improvement Vaccines Japan
    Improving Shared Decision Making in Hemophilia: Visiting Professorship Program - 2026, Semester 2
    Release Date:
    Partner: Hemostasis & Thrombosis Research Society (HTRS)
    Review Process: Expert Review Panel
    Education Rare Disease USA
    Development of Healthcare Professionals with Advanced Expertise in Preventive Strategies in Pediatric Infectious Diseases
    Release Date:
    Review Process: Pfizer Internal
    Translation: Japanese (link)
    Education Vaccines Japan
    Current and Emerging Therapies: The future of Recurrent or Metastatic (r/m) Cervical Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    The Role of RSV in Functional Decline and Healthcare Dependency in Hospitalized Adults
    Release Date:
    Review Process: Expert Review Panel
    Research Vaccines Italy
    Improving the Quality and Standardization of Pneumococcal Diagnostic Pathways in Pediatric and Adult Populations
    Release Date:
    Review Process: Expert Review Panel
    Research Vaccines Italy
    Interventional Research Studies of Brentuximab Vedotin-Based Novel Combinations in AITL and PTCL-NOS
    Release Date:
    Review Process: Pfizer Internal
    Research Oncology USA
    Optimizing Early Biomarker Testing to Guide Clinical Decision-Making in Colorectal Cancer Across Latin America
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Argentina, Brazil, Chile, Colombia, Mexico, Peru
    Optimizing Maternal RSV Immunization Delivery: A Systems-Based QI Initiative to Improve Uptake, Equity, and Newborn Outcomes
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement Vaccines USA
    Evolving Treatment Options in First-Line Metastatic Urothelial Carcinoma (mUC) and Muscle Invasive Bladder Cancer (MIBC)
    Release Date:
    Partner: Astellas
    Review Process: Expert Review Panel
    Education Oncology All
    Implementing Germline and Somatic Testing for Precision Medicine in Community-Based Prostate Cancer Care: Visiting Professorship
    Release Date:
    Partner: Prostate Cancer Foundation
    Review Process: Expert Review Panel
    Education Oncology USA
    Improving Venous Thromboembolism (VTE) Diagnosis and Treatment with Primary Care Settings- A Quality Improvement Project
    Release Date:
    Partner: American Academy of Family Physicians
    Review Process: Expert Review Panel
    Quality Improvement Internal Medicine USA
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Establishing Concordance in Vaccination
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines Japan
    Promoting Cognition of the Significance of Vaccination and Advancement in Accessibility
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines Japan
    Promoting Understanding and Improving Practices Related to Post-COVID-19 Symptoms
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital Japan
    Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research in Latin America
    Release Date:
    Review Process: Pfizer Internal
    Research Rare Disease All
    Optimizing Maternal Immunization Practice in Canada
    Release Date:
    Review Process: Pfizer Internal
    Translation: French (link)
    Quality Improvement Vaccines Canada
    Patient Preferences for Drug Delivery: Literature Review
    Release Date:
    Review Process: Expert Review Panel
    Research Support for the Professions All
    Global Awards for Research in DMD-AWARD
    Release Date:
    Review Process: Expert Review Panel
    Research Rare Disease All
    Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research in Canada
    Release Date:
    Review Process: Pfizer Internal
    Translation: French (link)
    Research Rare Disease Canada
    Relapsed/Refractory Multiple Myeloma
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Argentina, Brazil, India, Saudi Arabia, Singapore, Taiwan, Turkey
    Invasive Fungal Infections (Global excluding US)
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital All
    Early Identification and Diagnosis of Non-Alcoholic Steatohepatitis (NASH) in At-Risk Populations
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine All
    Advances in Migraine Therapy
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine USA
    Alopecia Areata (Global)
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology USA
    Advancing Health Literacy in The Republic of Ireland
    Release Date:
    Review Process: Expert Review Panel
    Education Support for the Professions Ireland
    Education to Improve Antimicrobial Resistance (AMR) Management
    Release Date:
    Partner: Japanese Society of Chemotherapy
    Review Process: Expert Review Panel
    Education Hospital Japan
    Education on the Appropriate Diagnosis and Treatment of Overactive Bladder or Neurogenic Bladder
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine Japan
    Promote the Streamline and Optimization of Healthcare System to Improve Regional Disparities
    Release Date:
    Partner: Japan Association for Development of Community Medicine
    Review Process: Expert Review Panel
    Quality Improvement Support for the Professions Japan
    Novel Digital Diagnostic Approaches in Acromegaly and Sickle Cell Disease
    Release Date:
    Review Process: Pfizer Internal
    Research Rare Disease USA
    Establishing Regional Medical Care Coordination System for Detailed examination of the Causes of Heart Failure
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Rare Disease Japan
    Improving Knowledge and Capability to Communicate Information on the Latest Hemophilia Treatments
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease Japan
    Ulcerative Colitis (UC) Research
    Release Date:
    Review Process: Expert Review Panel
    Research Inflammation & Immunology Albania, Andorra, Australia, Austria, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Holy See (Vatican City State), Hungary, Iceland, Ireland, Israel, Italy, Korea, Latvia, Liechtenstein, Lithuania, Luxembourg, Macedonia, The Former Yugoslav, Malta, Moldova, Republic of, Monaco, Netherlands, New Zealand, Norway, Poland, Portugal, Romania, San Marino, Slovakia (Slovak Republic), Slovenia, Spain, Sweden, Switzerland, Ukraine, United Kingdom
    Quality Improvement Grants to Support Development of Cardiac Amyloid Centers
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Rare Disease USA
    Quantifying the Socio-Economic Burden of Disease for Dermatology Patients and Caregivers
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology Australia, Austria, Belgium, Canada, Czech Republic, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Japan, Luxembourg, Netherlands, Norway, Poland, Portugal, Romania, Slovakia (Slovak Republic), Spain, Sweden, Switzerland, United Kingdom
    Evidence-informed treatment decisions in chronic inflammatory disorders
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement Inflammation & Immunology Australia
    Innovative digital educational channels in Oncology for health care professionals or patients to increase local awareness
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Spain
    Individualized Menopause Care
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine USA
    Approaches to Improve Delivery of Quality of Care for Patients with Inflammatory, and Immune Skin Diseases
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Inflammation & Immunology Japan
    Promoting Appropriate Diagnosis and Treatment of Migraine Care
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine Japan
    Burden of RSV Disease - Analyzing Local Surveillance Data for Older Adults (EM Geographic Scope)
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology All
    Improving Education Disparities of Non-Specialized Health Care Providers to Deliver Appropriate Medical Care for IBD Patients
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology Argentina, Brazil, India, Russia, Saudi Arabia, Singapore, Turkey, United Arab Emirates
    Increasing Understanding of the Evolving Hemophilia Treatment Landscape
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease USA
    Non-Muscle Invasive Bladder Cancer Emerging Markets Needs Assessment
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Argentina, Brazil, Colombia, Hong Kong, India, Mexico, Saudi Arabia, Taiwan, Turkey, United Arab Emirates
    Addressing Educational Barriers to Equitable Care for Patients with Immune Inflammatory Diseases
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology All
    Juvenile Idiopathic Arthritis (JIA) Patient Education
    Release Date:
    Review Process: Expert Review Panel
    Education Inflammation & Immunology USA
    Updates on RSV in Older Adults for Pharmacists
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines USA
    PARP-inhibitor Combination Treatments in Prostate Cancer, a Global Perspective
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    Updates in RSV Prevention for Prenatal Care Workers Serving Marginalized Communities
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines USA
    Acquired Aplastic Anemia: Educational programs to upskill hematologists & primary care physicians with current best practices
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital All
    Bridging the Inflammatory Dermatosis Care Divide with Teledermatology
    Release Date:
    Partner: The George Washington University
    Review Process: Expert Review Panel
    Quality Improvement Inflammation & Immunology USA
    Knowledge Gaps in Drug-Drug Interactions in COVID-19 Outpatient Treatment
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines USA
    Optimizing COVID-19 Treatment Strategies in Elderly Vulnerable Populations in Canada
    Release Date:
    Review Process: Pfizer Internal
    Translation: French (link)
    Quality Improvement Vaccines Canada
    Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research in Canada
    Release Date:
    Review Process: Pfizer Internal
    Translation: French (link)
    Research Rare Disease Canada
    Improving access to and the quality of clinical diagnostic solutions (Africa Geographic Scope)
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Support for the Professions All
    Patient Education and Support for the Management of Migraine
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine All
    Advancing Management and Care in Atrial Fibrillation and Venous Thromboembolism (ex-US)
    Release Date:
    Partner: Bristol-Myers Squibb
    Review Process: Pfizer Internal
    Education Internal Medicine All
    Raising Awareness and Promoting Timely Diagnosis of TTR Amyloidosis
    Release Date:
    Partner: Global Bridges at Mayo Clinic
    Review Process: Expert Review Panel
    Quality Improvement Rare Disease All
    Accord for a Healthier World: Antimicrobial Resistance Testing & Stewardship to Improve Hospitalized Patients’ Health Outcomes
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Hospital Malawi, Rwanda, Senegal
    Updates in Post-COVID Conditions: Potential Causes, Assessment, Testing, Management, and Ongoing Research
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines USA